Feed Top Reports Pricing

⌘K

17:19:13·29d

SECFiling

SEC Form 10-K filed by Immix Biopharma Inc.

IMMX· Immix Biopharma Inc.

Health Care

Full content unavailable. See the original source below.

Original source

Companies

IMMX
Immix Biopharma Inc.
Health Care

Recent analyst ratings

Mar 25UpdateMorgan Stanley$20.00
Mar 9UpdateCitizens$23.00
Feb 9UpdateMizuho$14.00

Related

PR14d
Immix Biopharma to Participate in the Jefferies Global Healthcare Conference
SEC17d
SEC Form DEFA14A filed by Immix Biopharma Inc.
SEC17d
SEC Form DEF 14A filed by Immix Biopharma Inc.
SEC24d
Immix Biopharma Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
SEC27d
Amendment: SEC Form 10-K/A filed by Immix Biopharma Inc.
SEC29d
SEC Form S-8 filed by Immix Biopharma Inc.
SEC29d
Immix Biopharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
SEC29d
SEC Form 424B5 filed by Immix Biopharma Inc.

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022